LEGISLATIVE BUDGET BOARD Austin, Texas FISCAL NOTE, 88TH LEGISLATIVE REGULAR SESSION April 25, 2023 TO: Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services FROM: Jerry McGinty, Director, Legislative Budget Board IN RE: SB1619 by Perry (Relating to the determination of prescription drug reimbursement amounts under the Medicaid vendor drug program.), As Introduced The fiscal implications of the bill cannot be determined due to the potential for costs related to the exclusion of discount prices from prescription drug reimbursement amounts under the Medicaid vendor drug program being unknown. The bill would direct the Health and Human Services Commission (HHSC) to exclude discount prices offered for a prescription drug from the usual and customary price. According to HHSC, the bill would have no fiscal impact on the agency, because currently pharmacies determine the usual and customary price, not HHSC. The fiscal implications of pharmacies excluding discount prices offered for prescription drugs, including third-party discount cards, cannot be determined at this time. Local Government ImpactNo fiscal implication to units of local government is anticipated. Source Agencies: b > td > 529 Health and Human Services Commission LBB Staff: b > td > JMc, NPe, ER, CST
LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 88TH LEGISLATIVE REGULAR SESSION
April 25, 2023
TO: Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services FROM: Jerry McGinty, Director, Legislative Budget Board IN RE: SB1619 by Perry (Relating to the determination of prescription drug reimbursement amounts under the Medicaid vendor drug program.), As Introduced
TO: Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services
FROM: Jerry McGinty, Director, Legislative Budget Board
IN RE: SB1619 by Perry (Relating to the determination of prescription drug reimbursement amounts under the Medicaid vendor drug program.), As Introduced
Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services
Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services
Jerry McGinty, Director, Legislative Budget Board
Jerry McGinty, Director, Legislative Budget Board
SB1619 by Perry (Relating to the determination of prescription drug reimbursement amounts under the Medicaid vendor drug program.), As Introduced
SB1619 by Perry (Relating to the determination of prescription drug reimbursement amounts under the Medicaid vendor drug program.), As Introduced
The fiscal implications of the bill cannot be determined due to the potential for costs related to the exclusion of discount prices from prescription drug reimbursement amounts under the Medicaid vendor drug program being unknown.
The fiscal implications of the bill cannot be determined due to the potential for costs related to the exclusion of discount prices from prescription drug reimbursement amounts under the Medicaid vendor drug program being unknown.
The bill would direct the Health and Human Services Commission (HHSC) to exclude discount prices offered for a prescription drug from the usual and customary price. According to HHSC, the bill would have no fiscal impact on the agency, because currently pharmacies determine the usual and customary price, not HHSC. The fiscal implications of pharmacies excluding discount prices offered for prescription drugs, including third-party discount cards, cannot be determined at this time.
Local Government Impact
No fiscal implication to units of local government is anticipated.
Source Agencies: b > td > 529 Health and Human Services Commission
529 Health and Human Services Commission
LBB Staff: b > td > JMc, NPe, ER, CST
JMc, NPe, ER, CST